Glioma targeted therapy: insight into future of molecular approachesKeyang Yang, Zhijing Wu, Hao Zhang et al.|Molecular Cancer|2022Cited by 727
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancerHao Zhang, Quan Cheng, Ziyu Dai et al.|Journal of Experimental & Clinical Cancer Research|2021Cited by 535
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging conceptsYuchen Wang, Quan Cheng, Hao Zhang et al.|Journal of Hematology & Oncology|2022Cited by 273
Machine learning-based identification of tumor-infiltrating immune cell-associated lncRNAs for improving outcomes and immunotherapy responses in patients with low-grade gliomaNan Zhang, Quan Cheng, Hao Zhang et al.|Theranostics|2022Cited by 152
The molecular feature of macrophages in tumor immune microenvironment of glioma patientsHao Zhang, Zhixiong Liu, Quan Cheng et al.|Computational and Structural Biotechnology Journal|2021Cited by 145